Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer
Rona Yaeger(Memorial Sloan Kettering Cancer Center), Sandra Misale(Johns Hopkins University), Edison Tse(Boundless Bio (United States)), Sudhir Chowdhry(Boundless Bio (United States)), Kenna Anderes(Mirati Therapeutics (United States)), Kalyani Chadalavada(Memorial Sloan Kettering Cancer Center), Scott W. Lowe(Memorial Sloan Kettering Cancer Center), Almudena Chaves Perez(Memorial Sloan Kettering Cancer Center), Qing Chang(Memorial Sloan Kettering Cancer Center), Yonina R. Murciano‐Goroff(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Michelangelo Marasco(Università Cattolica del Sacro Cuore), Bob T. Li(Memorial Sloan Kettering Cancer Center), Nicholas D. Socci, Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), Sydney Bowker(Memorial Sloan Kettering Cancer Center), HuiYong Zhao(Memorial Sloan Kettering Cancer Center), Esther Kaplun(Memorial Sloan Kettering Cancer Center), Riccardo Mezzadra(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center), Besnik Qeriqi(Memorial Sloan Kettering Cancer Center), Jenna Sinopoli(Memorial Sloan Kettering Cancer Center), Yijun Gao(Sun Yat-sen University), Arnaud Da Cruz Paula(Memorial Sloan Kettering Cancer Center), James G. Christensen, Jorge S. Reis‐Filho(AstraZeneca (France)), Jinru Shia(Memorial Sloan Kettering Cancer Center), Hirak Der‐Torossian(Mirati Therapeutics (United States)), Yingjie Zhu(Southwest Jiaotong University), Yu Bian(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Elisa de Stanchina(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k